Joshua Hexter is COO & CBO of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 511,833 shares of ORMP, which is worth approximately $1.21 Million. The most recent transaction as insider was on Nov 07, 2024, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 512K
6.23% 3M change
69.86% 12M change
Total Value Held $1.21 Million

Joshua Hexter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 5.54%
511,833 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
180,500 Added 27.25%
481,833 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
27,000 Added 8.22%
301,333 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
108,000 Added 28.25%
274,333 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
42,000 Added 20.16%
166,333 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
21,000 Added 14.45%
124,333 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
-
33,333 Added 24.39%
103,333 Common Stock
JH

Joshua Hexter

COO & CBO
Jerusalem, L3

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP